High expression of FUBP1 correlated with poor OS and RFS (relapse-free survival) in cervical squamous cell carcinoma, esophageal adenocarcinoma, kidney renal papillary cell carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, pancreatic ductal adenocarcinoma, sarcoma, pheochromocytoma and paraganglioma (p < 0.05). This evidence concerns the gene FUBP1 and sarcoma.